skip to main content

News Archive

Date: 10/16/2023
Every year, health plans offer open enrollment – a time to reassess your benefits and select new options. But is it worth the hassle to change plans? For people with expensive prescription drugs, switching plans could save them thousands of dollars in copays. And a simple tool can help people easily compare out-of-pockets expenses for anyone with a Medicare Part D prescription plan.
Date: 10/13/2023
University of Michigan Health will purchase the Edison platform used to deliver histotripsy, a technology pioneered at the university that uses sound waves to destroy tissue. HistoSonics, a company co-founded by U-M faculty, received approval this week from the U.S. Food and Drug Administration to use histotripsy via the Edison platform in liver treatment.
Date: 10/12/2023
The annual hospital review included the cancer center on their list of elite programs around the county.
Date: 10/09/2023
Pioneered at the University of Michigan, histotripsy offers a promising alternative to cancer treatments such as surgery, radiation and chemotherapy, which often have significant side effects. Today, FDA officials awarded clearance to HistoSonics, a company co-founded in 2009 by U-M engineers and doctors for the use of histotripsy to destroy targeted liver tissue.
Date: 09/26/2023
A gene sequencing method called ribosome profiling has expanded our understanding of the human genome by identifying previously unknown protein coding regions. Also known as Ribo-seq, this method allows researchers to get a high-resolution snapshot of protein production in cells.
Date: 09/20/2023
Rogel Cancer Center faculty and trainees will lead more than 20 presentations, posters and moderated sessions at ASTRO 2023 held October 1-4, at the San Diego Convention Center, San Diego, CA.
Date: 09/14/2023
An inter-departmental group of researchers at the Rogel Cancer Center received a grant from the National Cancer Institute to further research on radiosensitization, the process of making tumors more vulnerable to radiation treatment.
Date: 09/11/2023
A free online tool could potentially save some prostate cancer patients more than $9,000 in out-of-pocket drug costs, a study finds. For patients enrolled in Medicare Part D prescription drug plans, out of pocket costs can vary significantly.
Date: 09/08/2023
Historically, genetic testing for cancer risk has been underutilized, especially in underserved communities. The MiGHT Project aims to help Michigan residents at increased risk of cancer get access to clinical genetic testing.
Date: 09/08/2023
To address cancer health disparities in the Native American community, Rogel’s Community Outreach and Engagement team partnered with the Little Traverse Bay Band of Odawa Indians to conduct two motivational interviewing training sessions for care providers from the Good Health Lodge and Crooked Tree Wellness Clinic in Petoskey. The training teaches staff how to communicate with their patients more effectively to lead to better health outcomes.

Pages